Page last updated: 2024-12-06

tetrahydrocorticosterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetrahydrocorticosterone (THB) is a steroid hormone that is a metabolite of cortisol. It is produced in the adrenal glands and is involved in the regulation of stress response and energy metabolism. THB is not as potent as cortisol, but it has a longer half-life. It is studied for its potential role in various physiological processes, including inflammation, immune function, and cardiovascular health. Research suggests that THB may have anti-inflammatory effects and may contribute to the regulation of blood pressure.'

tetrahydrocorticosterone: RN given refers to (3alpha,5beta,11beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65553
CHEBI ID9481
SCHEMBL ID1331548
MeSH IDM0044736

Synonyms (26)

Synonym
3alpha,11beta,21-5alpha-trihydroxy-pregnane-20-one
LMST02030100
tetrahydrocorticosterone
68-42-8
C05476
1-[(3r,5r,8s,9s,10s,11s,13s,14s,17s)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone
SCHEMBL1331548
unii-puw84k2lec
puw84k2lec ,
einecs 200-690-5
3alpha,11beta,21-trihydroxy-5beta-pregnan-20-one
CHEBI:9481
5b-pregnane-3a,11b,21-triol-20-one
(3a,5b,11b)-3,11,21-trihydroxy-pregnan-20-one
tetrahydro-corticosterone
3a,11b,21-trihydroxy-5b-pregnan-20-one
3a,5b-tetrahydrocorticosterone
DTXSID901015843
thb (tetrahydrocorticosterone)
pregnan-20-one, 3,11,21-trihydroxy-, (3.alpha.,5.beta.,11.beta.)-
5.beta.-pregnan-20-one, 3.alpha.,11.beta.,21-trihydroxy-
5.beta.-pregnane-3.alpha.,11.beta.,21-triol-20-one
corticosterone, tetrahydro-
3.alpha.,11.beta.,21-trihydroxy-5.beta.-pregnan-20-one
3.alpha.,5.beta.-tetrahydrocorticosterone
(3.alpha.,5.beta.,11.beta.)-3,11,21-trihydroxypregnan-20-one

Research Excerpts

Overview

5α-Tetrahydrocorticosterone (5αTHB) is an effective topical anti-inflammatory agent in mouse. It has less propensity to cause skin thinning and impede new blood vessel growth compared with corticosterone.

ExcerptReferenceRelevance
"5α-Tetrahydrocorticosterone (5αTHB) is an effective topical anti-inflammatory agent in mouse, with less propensity to cause skin thinning and impede new blood vessel growth compared with corticosterone. "( Comparison of mechanisms of angiostasis caused by the anti-inflammatory steroid 5α-tetrahydrocorticosterone versus conventional glucocorticoids.
Abernethie, AJ; Andrew, R; Gastaldello, A; Hadoke, PW; Livingstone, DE; Maltese, G; McInnes, KJ; Morgan, RA; Small, GR; Walker, BR, 2022
)
1.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
21-hydroxy steroid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Mineralocorticoid biosynthesis08
Biochemical pathways: part I0466

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (22.58)18.7374
1990's3 (9.68)18.2507
2000's13 (41.94)29.6817
2010's7 (22.58)24.3611
2020's1 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.67 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]